GSK signs oncology deal with UK biotech

May 18, 2009
Research and Development, Sales and Marketing GSK, Oxford Biotherapeutics

GSK has struck a deal with Oxford BioTherapeutics to develop therapies for primary, metastatic and recurring forms of cancer. The …

Sanofi-Aventis starts work on dengue fever plant

May 15, 2009
Manufacturing and Production Sanofi-Aventis

Sanofi-Aventis' vaccine subsidiary Sanofi Pasteur has broken ground on a 350 million euro facility devoted to the producing a vaccine …

Sanofi-Aventis signs deal with Japanese biotech

May 15, 2009
Research and Development, Sales and Marketing Sanofi-Aventis

Sanofi-Aventis has signed an early-stage research deal with biotech Kyowa Hakko Kirin, and will receive rights to its preclinical stage …

Kendle trims down as profits slump

May 15, 2009
Research and Development Kendle

Contract research organisation Kendle joined many of its peers in reporting a slump in demand for its clinical research services …

Cohn & Wolfe takes on hepatitis C and substance misuse brief

May 15, 2009
Medical Communications Cohn&Wolfe

PR agency Cohn & Wolfe is to handle communications for Schering-Plough's substance misuse and hepatitis C portfolio. It will work …

Boehringer signs diabetes and obesity deal

May 14, 2009
Research and Development, Sales and Marketing Boehringer

Boehringer Ingelheim has signed a deal with German biopharma firm DeveloGen to research and develop treatments for diabetes and obesity. …

NHS generic drive saves

May 14, 2009
Sales and Marketing NHS

The NHS saved £394 million last year by prescribing cheaper generic medicines, according to an academic study. The Department of …

Does it still pay to be a loyal employee?

May 14, 2009
Business Services loyalty, recruitment

Few people can expect to have 'a job for life' anymore, where employees could expect to stay with the same …

Kennedy sets out views on NICE’s future

May 14, 2009
Research and Development NICE

Two stakeholder workshops which could shape NICE's future direction are to be held next week. Professor Sir Ian Kennedy has …

API market growth driven by biologics

May 13, 2009
Manufacturing and Production biologics

The global market for active pharmaceutical ingredients is being transformed as big pharma companies devote more and more resources to …

Dragon James Caan invests in CSO Star

May 13, 2009
Business Services Star

Star, a specialist contract sales organisation and healthcare recruiter, has won the backing of Dragon's Den investor James Caan. The …

AstraZeneca buoyed as Brilinta tops Plavix in trial

May 13, 2009
Research and Development, Sales and Marketing AZ, Brillinta

AstraZeneca has been lifted by clinical results indicating its antiplatelet drug Brilinta outperformed Sanofi-Aventis/Bristol-Myers Squibb’s Plavix – currently the world’s …

Pharma manufacturing: news in brief

May 12, 2009
Manufacturing and Production Genzyme

Pharmafocus presents a round-up of developments in the pharmaceutical manufacturing sector, including new capital investments at Roche, Genzyme and Aeras, …

GSK boosts stake in Aspen

May 12, 2009
Sales and Marketing GSK, generics

GlaxoSmithKline has extended its stake in the South African generics company Aspen to a 16% shareholding. In return it will …

Working Life: Nick Rodgers

May 12, 2009
Sales and Marketing WL, Working Life, marketing, product manager

How did you find your way into your current role?I started my pharma career at Schering Healthcare as a representative …

UK a step closer to new swine flu vaccine

May 11, 2009
Research and Development NHS, h1n1

The first step towards producing a European prototype of a swine flu vaccine has been achieved by the UK's Health …

GSK claims superiority for Cervarix in head-to-head trial

May 11, 2009
Research and Development, Sales and Marketing GSK, vaccines

GlaxoSmithKline says a new study shows its cervical cancer vaccine Cervarix induces a higher immune response compared to rival Gardasil. …

Cmed and Tessella join forces on adaptive trials

May 11, 2009
Research and Development Cmed, digi

UK contract research organisation Cmed Research has bolstered its ability to carry out adaptive clinical trials on behalf of clients …

Sanofi hikes flu vaccine capacity with new US plant

May 11, 2009
Manufacturing and Production Sanofi-Aventis, h1n1

Sanofi-Aventis has been given a green light for a new $150 million flu vaccine manufacturing plant in the US that …

The Gateway to Local Adoption Series

Latest content